Details for New Drug Application (NDA): 211618
✉ Email this page to a colleague
The generic ingredient in DOXEPIN HYDROCHLORIDE is doxepin hydrochloride. There are seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
Summary for 211618
Tradename: | DOXEPIN HYDROCHLORIDE |
Applicant: | Leading |
Ingredient: | doxepin hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 211618
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 211618 | ANDA | Leading Pharma, LLC | 69315-163 | 69315-163-01 | 100 CAPSULE in 1 PACKAGE (69315-163-01) |
DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 211618 | ANDA | Leading Pharma, LLC | 69315-163 | 69315-163-05 | 500 CAPSULE in 1 PACKAGE (69315-163-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Mar 1, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription